2024-04-03 |
2024-04-01 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
3,000
+0.1%
19.08
57,240
USD
|
3,000
+0.1%
|
19.08
|
57,240
USD
|
|
2024-03-26 |
2024-03-22 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,500
+0.0%
19.98
49,950
USD
|
2,500
+0.0%
|
19.98
|
49,950
USD
|
|
2024-03-22 |
2024-03-20 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,500
+0.0%
17.68
26,520
USD
|
1,500
+0.0%
|
17.68
|
26,520
USD
|
|
2024-03-07 |
2024-03-05 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
30,500
+0.6%
12.49
380,945
USD
|
30,500
+0.6%
|
12.49
|
380,945
USD
|
|
2024-03-06 |
2024-03-04 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
4,100
+0.1%
13.03
53,423
USD
|
4,100
+0.1%
|
13.03
|
53,423
USD
|
|
2024-02-21 |
2024-02-16 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
10,800
+0.2%
11.16
120,528
USD
|
10,800
+0.2%
|
11.16
|
120,528
USD
|
|
2024-02-20 |
2024-02-15 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
12,700
+0.2%
11.07
140,589
USD
|
12,700
+0.2%
|
11.07
|
140,589
USD
|
|
2023-11-14 |
2023-11-10 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
5,000
+0.1%
10.17
50,838
USD
|
5,000
+0.1%
|
10.17
|
50,838
USD
|
|
2023-11-07 |
2023-11-03 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
3,500
+0.1%
9.11
31,885
USD
|
3,500
+0.1%
|
9.11
|
31,885
USD
|
|
2023-10-31 |
2023-10-27 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
500
+0.2%
8.57
4,285
USD
|
500
+0.2%
|
8.57
|
4,285
USD
|
|
2023-10-30 |
2023-10-26 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,500
+0.0%
7.97
19,925
USD
|
2,500
+0.0%
|
7.97
|
19,925
USD
|
|
2023-10-27 |
2023-10-25 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,500
+0.0%
7.91
19,775
USD
|
2,500
+0.0%
|
7.91
|
19,775
USD
|
|
2023-10-12 |
2023-10-10 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
9.07
9,070
USD
|
1,000
+0.0%
|
9.07
|
9,070
USD
|
|
2023-10-05 |
2023-10-04 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,000
+0.0%
8.63
17,260
USD
|
2,000
+0.0%
|
8.63
|
17,260
USD
|
|
2023-09-28 |
2023-09-26 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
600
+0.2%
8.71
5,226
USD
|
600
+0.2%
|
8.71
|
5,226
USD
|
|
2023-09-21 |
2023-09-19 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
4,000
+0.1%
8.95
35,800
USD
|
4,000
+0.1%
|
8.95
|
35,800
USD
|
|
2023-09-13 |
2023-09-11 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
9.48
9,480
USD
|
1,000
+0.0%
|
9.48
|
9,480
USD
|
|
2023-08-24 |
2023-08-22 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
9.97
9,970
USD
|
1,000
+0.0%
|
9.97
|
9,970
USD
|
|
2023-08-08 |
2023-08-04 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,000
+0.0%
10.55
21,100
USD
|
2,000
+0.0%
|
10.55
|
21,100
USD
|
|
2023-07-25 |
2023-07-21 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
9.20
9,200
USD
|
1,000
+0.0%
|
9.20
|
9,200
USD
|
|
2023-07-17 |
2023-07-13 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
250
+0.1%
9.49
2,373
USD
|
250
+0.1%
|
9.49
|
2,373
USD
|
|
2023-05-18 |
2023-05-17 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
11.69
11,690
USD
|
1,000
+0.0%
|
11.69
|
11,690
USD
|
|
2023-05-02 |
2023-04-28 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
250
+0.1%
11.22
2,805
USD
|
250
+0.1%
|
11.22
|
2,805
USD
|
|
2023-04-21 |
2023-04-19 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
7,000
+0.1%
11.10
77,700
USD
|
7,000
+0.1%
|
11.10
|
77,700
USD
|
|
2023-04-20 |
2023-04-18 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,000
+0.0%
11.12
22,240
USD
|
2,000
+0.0%
|
11.12
|
22,240
USD
|
|
2023-04-12 |
2023-04-11 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
5,000
+0.1%
12.42
62,100
USD
|
5,000
+0.1%
|
12.42
|
62,100
USD
|
|
2023-04-12 |
2023-04-11 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
1,000
+0.4%
11.87
11,870
USD
|
1,000
+0.4%
|
11.87
|
11,870
USD
|
|
2023-03-16 |
2023-03-15 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
250
+0.1%
12.71
3,178
USD
|
250
+0.1%
|
12.71
|
3,178
USD
|
|
2023-03-13 |
2023-03-10 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
12.12
12,120
USD
|
1,000
+0.0%
|
12.12
|
12,120
USD
|
|
2023-02-28 |
2023-02-24 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
250
+0.1%
15.40
3,849
USD
|
250
+0.1%
|
15.40
|
3,849
USD
|
|
2023-02-22 |
2023-02-17 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
600
+0.0%
16.53
9,918
USD
|
600
+0.0%
|
16.53
|
9,918
USD
|
|
2023-02-14 |
2023-02-10 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
18.68
18,680
USD
|
1,000
+0.0%
|
18.68
|
18,680
USD
|
|
2023-02-07 |
2023-02-03 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
250
+0.1%
20.84
5,210
USD
|
250
+0.1%
|
20.84
|
5,210
USD
|
|
2023-01-31 |
2023-01-27 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,000
+0.1%
19.35
38,700
USD
|
2,000
+0.1%
|
19.35
|
38,700
USD
|
|
2023-01-30 |
2023-01-27 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
250
+0.1%
19.20
4,800
USD
|
250
+0.1%
|
19.20
|
4,800
USD
|
|
2023-01-24 |
2023-01-20 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,500
+0.1%
17.37
26,055
USD
|
1,500
+0.1%
|
17.37
|
26,055
USD
|
|
2023-01-17 |
2023-01-13 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
250
+0.1%
16.50
4,125
USD
|
250
+0.1%
|
16.50
|
4,125
USD
|
|
2023-01-10 |
2023-01-06 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,500
+0.1%
15.18
22,770
USD
|
1,500
+0.1%
|
15.18
|
22,770
USD
|
|
2023-01-03 |
2022-12-29 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
4,000
+0.1%
15.19
60,760
USD
|
4,000
+0.1%
|
15.19
|
60,760
USD
|
|
2022-12-20 |
2022-12-16 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
250
+0.1%
12.94
3,235
USD
|
250
+0.1%
|
12.94
|
3,235
USD
|
|
2022-12-20 |
2022-12-16 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
13.01
13,010
USD
|
1,000
+0.0%
|
13.01
|
13,010
USD
|
|
2022-12-13 |
2022-12-09 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,000
+0.1%
13.11
26,220
USD
|
2,000
+0.1%
|
13.11
|
26,220
USD
|
|
2022-12-06 |
2022-12-02 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
13.84
13,840
USD
|
1,000
+0.0%
|
13.84
|
13,840
USD
|
|
2022-12-06 |
2022-12-02 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
250
+0.1%
13.98
3,495
USD
|
250
+0.1%
|
13.98
|
3,495
USD
|
|
2022-11-04 |
2022-11-02 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,000
+0.1%
8.79
17,580
USD
|
2,000
+0.1%
|
8.79
|
17,580
USD
|
|
2022-10-17 |
2022-10-14 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
3,000
+0.1%
9.75
29,250
USD
|
3,000
+0.1%
|
9.75
|
29,250
USD
|
|
2022-10-11 |
2022-10-07 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,000
+0.1%
9.72
19,440
USD
|
2,000
+0.1%
|
9.72
|
19,440
USD
|
|
2022-10-04 |
2022-09-30 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
9.46
9,460
USD
|
1,000
+0.0%
|
9.46
|
9,460
USD
|
|
2022-10-03 |
2022-09-29 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.0%
9.23
9,230
USD
|
1,000
+0.0%
|
9.23
|
9,230
USD
|
|
2022-06-27 |
2022-06-24 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
6,465
+0.2%
9.13
59,025
USD
|
6,465
+0.2%
|
9.13
|
59,025
USD
|
|
2022-06-27 |
2022-06-24 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
22,535
+0.8%
9.13
205,745
USD
|
22,535
+0.8%
|
9.13
|
205,745
USD
|
|
2022-06-17 |
2022-06-16 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
8,000
+0.3%
7.13
57,040
USD
|
8,000
+0.3%
|
7.13
|
57,040
USD
|
|
2022-06-15 |
2022-06-14 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
12,000
+0.5%
7.91
94,920
USD
|
12,000
+0.5%
|
7.91
|
94,920
USD
|
|
2022-06-13 |
2022-06-10 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
12,000
+0.5%
8.33
99,960
USD
|
12,000
+0.5%
|
8.33
|
99,960
USD
|
|
2022-06-10 |
2022-06-09 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
4,500
+0.4%
10.90
49,050
USD
|
4,500
+0.4%
|
10.90
|
49,050
USD
|
|
2022-06-08 |
2022-06-07 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
6,000
+0.5%
8.55
51,300
USD
|
6,000
+0.5%
|
8.55
|
51,300
USD
|
|
2022-06-06 |
2022-06-03 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
9,250
+0.8%
8.35
77,238
USD
|
9,250
+0.8%
|
8.35
|
77,238
USD
|
|
2022-06-03 |
2022-06-02 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
6,774
+0.6%
7.38
49,992
USD
|
6,774
+0.6%
|
7.38
|
49,992
USD
|
|
2022-04-26 |
2022-04-25 |
B
Purchase
|
Daugherty Frank Joseph
Chief Medical Officer
Executive Director
|
1,000
+1.1%
16.25
16,250
USD
|
1,000
+1.1%
|
16.25
|
16,250
USD
|
|
2022-04-22 |
2022-04-21 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
6,000
+0.5%
16.09
96,540
USD
|
6,000
+0.5%
|
16.09
|
96,540
USD
|
|
2022-04-21 |
2022-04-19 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
6,000
+0.5%
16.74
100,440
USD
|
6,000
+0.5%
|
16.74
|
100,440
USD
|
|
2022-04-20 |
2022-04-19 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
500
+0.2%
16.74
8,370
USD
|
500
+0.2%
|
16.74
|
8,370
USD
|
|
2022-02-14 |
2022-02-11 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
5,500
+0.5%
19.80
108,900
USD
|
5,500
+0.5%
|
19.80
|
108,900
USD
|
|
2022-02-08 |
2022-02-04 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
5,000
+0.4%
19.59
97,950
USD
|
5,000
+0.4%
|
19.59
|
97,950
USD
|
|
2022-02-01 |
2022-01-31 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
500
+0.2%
18.47
9,235
USD
|
500
+0.2%
|
18.47
|
9,235
USD
|
|
2022-01-24 |
2022-01-21 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg Affairs
Officer
|
500
+0.2%
16.33
8,165
USD
|
500
+0.2%
|
16.33
|
8,165
USD
|
|
2022-01-24 |
2022-01-21 |
B
Purchase
|
Hallock Kenneth
Non-Executive Director
|
300
+0.1%
16.32
4,896
USD
|
300
+0.1%
|
16.32
|
4,896
USD
|
|
2022-01-19 |
2022-01-18 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg. Affairs
Officer
|
500
+0.2%
18.87
9,435
USD
|
500
+0.2%
|
18.87
|
9,435
USD
|
|
2022-01-18 |
2022-01-13 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,000
+0.1%
19.99
19,990
USD
|
1,000
+0.1%
|
19.99
|
19,990
USD
|
|
2022-01-14 |
2022-01-13 |
B
Purchase
|
Daugherty Frank Joseph
Chief Medical Officer
Executive Director
|
1,000
+1.1%
19.99
19,990
USD
|
1,000
+1.1%
|
19.99
|
19,990
USD
|
|
2022-01-14 |
2022-01-13 |
B
Purchase
|
Thompson Jaye
VP Clinical Reg. Affairs
Officer
|
1,000
+0.4%
19.99
19,990
USD
|
1,000
+0.4%
|
19.99
|
19,990
USD
|
|
2022-01-04 |
2022-01-03 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
2,050
+0.2%
23.82
48,831
USD
|
2,050
+0.2%
|
23.82
|
48,831
USD
|
|
2021-12-16 |
2021-12-14 |
B
Purchase
|
Daugherty Frank Joseph
Chief Medical Officer
Executive Director
|
1,111
+1.3%
26.99
29,983
USD
|
1,111
+1.3%
|
26.99
|
29,983
USD
|
|
2021-12-16 |
2021-12-14 |
B
Purchase
|
Patel Snehal
CEO and CFO
Executive Director
Major owner
|
1,840
+0.2%
27.17
49,992
USD
|
1,840
+0.2%
|
27.17
|
49,992
USD
|
|
2021-12-16 |
2021-12-14 |
B
Purchase
|
McWilliams David
Non-Executive Director
|
200
+0.0%
27.56
5,512
USD
|
200
+0.0%
|
27.56
|
5,512
USD
|
|